|
GB202015058D0
|
|
Nanostructured necleic acids vaccines
|
|
GB202005599D0
|
|
Modulation of t cell cytotoxicity and related therapy
|
|
GB201915469D0
|
|
Cancer detection methods
|
|
GB201901439D0
|
|
Method of predicting survival rates for cancer patients
|
|
GB201705863D0
|
|
Pyridinium salts and uses thereof
|
|
WO2014155102A1
|
|
Method and apparatus for producing polymeric structures
|
|
US2014036388A1
|
|
System and method for manipulating domain pinning and reversal in ferromagnetic materials
|
|
AU2012247013A1
|
|
Colonic drug delivery formulation
|
|
GB0917238D0
|
|
Blockade of voltage dependent sodium channels
|
|
GB0904928D0
|
|
Universal partitioning system
|
|
GB0904803D0
|
|
Coated substrate
|
|
GB0805492D0
|
|
Improvements in or relating to the delivery of contrast agents
|
|
GB201001916D0
|
|
A method of proliferating human hepatocyte cells
|
|
GB0713074D0
|
|
A method of hyperpolarising a magnetic resonance agent
|
|
US2007254062A1
|
|
Newborn infant formulas and feeding methods
|
|
TW200848091A
|
|
Colonic drug delivery formulation
|
|
GB0620823D0
|
|
Histone deacetylase inhibitors
|
|
GB0617669D0
|
|
Magnetic microspheres
|
|
GB0614545D0
|
|
Coating Film
|
|
GB0611774D0
|
|
Automatic quantification of changes in images
|
